Scientists make advancement in reducing MS severity
Monday, August 24th, 2009LONDON - University of Bristol scientists have made a major breakthrough in reducing the severity of multiple sclerosis (MS).
LONDON - University of Bristol scientists have made a major breakthrough in reducing the severity of multiple sclerosis (MS).
WASHINGTON - Cigarette smoking can cause brain damage in patients with multiple sclerosis (MS), according to a new study.
WASHINGTON - A cheap blood pressure drug could help keep multiple sclerosis at bay, claim researchers at the Stanford University School of Medicine.
Novartis says FDA approves interferon drug for MS
NEW YORK — Novartis AG said Monday the U.S. Food and Drug Administration approved its drug Extavia, a form of interferon intended to treat multiple sclerosis.
TORONTO - Canadian researchers have successfully reversed multiple sclerosis in rodents, spelling hope for humans.
LONDON - In a breakthrough study, researchers have successfully reversed multiple sclerosis in mice with the help of a new experimental treatment.
WASHINGTON - Researchers have revealed that cognitive testing, gender and brain lesions might help people with inactive or benign multiple sclerosis (MS) better predict their future with the disease.
Medical marijuana dispensaries thrive in Colo.
BOULDER, Colo. — Boulder County Caregivers offers 16 glass jars of marijuana with names like Skinny Pineapple and Early Pearl Maui, priced at $375 to $420 an ounce. There are marijuana capsules and snacks made with cannabis butter, such as rice crispy treats.
Merck Q2 net profit falls 48 percent to €109 M
FRANKFURT — German drug and chemical maker Merck KGaA said Friday its second quarter net profit fell 48 percent as higher research costs and one-time effects from the acquisition of Serono weighed on the bottom line.
Merck net profit falls 48 percent to $153 million
FRANKFURT — German drug and chemical maker Merck KGaA said Friday its second quarter net profit fell 48 percent as higher research costs and one-time effects from the acquisition of Serono weighed on the bottom line.